Skip to content

Effect of Aqueous Extract of Seed of Broccoli and Hericium Polypeptide Powder on the Helicobacter Pylori Infection: A Randomized, Double-Blinded, Placebo-Controlled Trial

Effect of Aqueous Extract of Seed of Broccoli and Hericium Polypeptide Powder on the Helicobacter Pylori Infection: A Randomized, Double-Blinded, Placebo-Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054249
Enrollment
Unknown
Registered
2021-12-11
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Intervention group B:Aqueous extract of seed of broccoli
Control group:Placebo

Sponsors

Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 20-70 years; 2. Diagnosed as HP infection positive; 3. BMI ranged from 18-30 kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Allergic constitution or allergic to the test sample; 3. Combined with serious diseases such as heart, liver, kidney and hematopoietic system, mental patients; 4. Drugs known to damage gastrointestinal function have been used within 3 months; 5. Patients who are using other nutritional preparations that may affect the experimental effect; 6. Patients who are using drugs that may affect the experimental effect (such as non-steroidal anti-inflammatory drugs or anticoagulants, etc.); 7. Patients with severe peptic ulcer; 8. Not taking it as prescribed, unable to judge the efficacy, or incomplete information; 9. Those who did not sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Helicobacter pylori infection;

Secondary

MeasureTime frame
Pepsinogen;Inflammation marker;

Countries

China

Contacts

Public ContactJing Lipeng

Lanzhou University

jinglp103@163.com+86 15293197918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026